A new oral medication, daraxonrasib, produced striking results in a phase 3 trial for people with pancreatic cancer, offering hope against one of the deadliest cancers.
Eli Lilly’s experimental drug retatrutide produced unprecedented weight loss in a phase 3 trial, with results that approach those seen after bariatric surgery and exceed outcomes from…
A new analysis of U.S. bariatric surgery data shows a notable decline in procedures as prescriptions for GLP‑1 weight-loss drugs and other nonsurgical programs have surged.
Barbara Roberts was 44 when a persistent fever landed her in the emergency room in December 1996 and she learned she had HIV.
A phase II randomized clinical trial reported promising results for (Z)-endoxifen, a metabolite of tamoxifen, as a lower-dose option to reduce mammographic breast density — a marker…
The Food and Drug Administration has prevented publication of multiple government-funded safety studies on widely used COVID-19 vaccines and the shingles vaccine Shingrix, prompting…
The NHS spring COVID-19 vaccination programme starts this week, offering potentially lifesaving protection to millions of older people and those with weakened immune systems.
A 63-year-old man in Norway has been documented in long-term remission from HIV after receiving an allogeneic hematopoietic stem cell transplant (HSCT) from his brother.
A review published in JAMA Network Open examined how social media influencers shape what people learn about and how they approach prescription medications, and found that influencer…
A large observational analysis of U.S. health records suggests that long-term use of some drugs prescribed for irritable bowel syndrome (IBS) is associated with a small but…
The NHS has widened its RSV vaccination programme, making the jab available to all adults aged 80 and over and to residents of older adult care homes — an expansion that extends…
A federal judge has struck down new childhood vaccination guidance issued in January by the U.S. Department of Health and Human Services under Health Secretary Robert F.